Title : Reductions in glucosylsphingosine (lyso-Gb1) in treatment-naïve and previously treated patients receiving velaglucerase alfa for type 1 Gaucher disease: Data from phase 3 clinical trials.

Pub. Date : 2017 Sep

PMID : 28851512






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Lyso-Gb1 (glucosylsphingosine, lyso-GL1), a downstream metabolic product of glucosylceramide, has been identified as a promising biomarker for the diagnosis and monitoring of patients with GD. Glucosylceramides gamma-aminobutyric acid type B receptor subunit 1 Homo sapiens